397 related articles for article (PubMed ID: 20632562)
1. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
Sadeghi M; Raisali G; Hosseini SH; Shavar A
Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
Sowards KT
J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
[TBL] [Abstract][Full Text] [Related]
5. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
Sadeghi M; Hosseini SH; Raisali G
Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric study of a new polymer encapsulated palladium-103 seed.
Bernard S; Vynckier S
Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
[TBL] [Abstract][Full Text] [Related]
8. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Rivard MJ; Melhus CS; Kirk BL
Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
[TBL] [Abstract][Full Text] [Related]
13. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
Monroe JI; Williamson JF
Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
[TBL] [Abstract][Full Text] [Related]
16. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
17. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
18. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo calculations of dosimetry parameters of the urocor prostaseed 125I source.
Li Z
Med Phys; 2002 Jun; 29(6):1029-34. PubMed ID: 12094972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]